期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 50, 期 26, 页码 6462-6464出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm7011497
关键词
-
资金
- NINDS NIH HHS [U01 NS058087-01, U01 NS058087, U01NS058087-01] Funding Source: Medline
A series of prodrugs of 3-mercaptopyruvate (3-MP), the substrate for the enzyme 3-mercaptopyruvate/cyanide sulfurtransferase (3-MPST) that converts cyanide to the nontoxic thiocyanate, which are highly effective cyanide antidotes, have been developed. These prodrugs of 3-MP are unique in being not only orally. bioavailable, but may be administered up to an hour prior to cyanide as a prophylactic agent and are both rapid- or slow-acting when given parenterally.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据